The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
How can we achieve global equity in provision of renal replacement therapy?
Open accessAbstract
There is a significant emerging burden of chronic and end-stage kidney disease in low- and middle-income countries, driven by population ageing and the global epidemic of type 2 diabetes. Sufferers of end-stage kidney disease require ongoing dialysis or kidney transplantation to survive; however, in many low- and middle-income countries, treatment options are strictly limited or unaffordable. Low numbers of maintenance dialysis patients and transplant recipients reflect profound economic and service provision challenges for health-care systems in low- and middle-income countries in sustaining renal replacement therapy programmes. Underdeveloped organ donor and transplant programmes, health system and financing issues, ethical regulation of transplantation and the cost of pharmaceuticals commonly pose additional barriers to the delivery of efficient and cost-effective renal replacement therapy. Development of locally appropriate transplant programmes, effective use of nongovernmental sources of funding, service planning and cost containment, use of generic drugs and local manufacture of dialysis consumables have the potential to make life-saving renal replacement therapy available to many more in need. Select low- and middle-income countries demonstrate more equitable provision of renal replacement therapy is possible outside high-income countries. For other low- and middle-income countries, education, the development of good public policy and a supportive international environment are critical. Prevention of end-stage kidney disease, ideally as part of an integrated approach to chronic vascular diseases, must also be a key objective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Home visits: a strategy to improve newborn survival - Authors' reply
(2008) · Americanae (AECID Library) · doi:10.1016/s0140 · Cited by 22,524
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
Wolfe, R. A., Ashby, V. B., Milford, E. L., Ojo, A. O., Ettenger, R. E., Agodoa, L. Y. C., Held, P. J., & Port, F. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912023412303 · Cited by 5,371
(2013) · Gastroenterology Research · doi:10.1053/j · Cited by 2,759
The first known larva of the Australian tribe Mystropomini (Coleoptera: Carabidae: Paussinae)
Giulio, A. D., & Moore, W. (2009) · Intellectum (Universidad de La Sabana) · doi:10.1111/j.1440- · Cited by 2,271
The Quality of Life of Patients with End-Stage Renal Disease
Evans, R. W., Manninen, D. L., Garrison, L. P., Hart, L. G., Blagg, C. R., Gutman, R. A., Hull, A. R., & Lowrie, E. G. (1985) · New England Journal of Medicine · doi:10.1056/nejm198502283120905 · Cited by 1,183
Sachs, J. D. (2001) · World Health Organization eBooks · Cited by 800
Chronic renal diseases as a public health problem: Epidemiology, social, and economic implications
Schieppati, A., & Remuzzi, G. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09801.x · Cited by 447
Economic and Health Consequences of Selling a Kidney in India
Goyal, M. (2002) · JAMA · doi:10.1001/jama.288.13.1589 · Cited by 417
The incidence of end-stage renal disease in India: A population-based study
Modi, G. K., & Jha, V. (2006) · Kidney International · doi:10.1038/sj.ki.5001958 · Cited by 348
Gaziano, T. A., Opie, L. H., & Weinstein, M. C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69252-0 · Cited by 274
End-stage renal disease in India and Pakistan: Burden of disease and management issues
Sakhuja, V., & Sud, K. (2003) · Kidney International · doi:10.1046/j.1523-1755.63.s83.24.x · Cited by 209
ESRD patients in 2001: global overview of patients, treatment modalities and development trends
Moeller, S. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.12.2071 · Cited by 185
The dangers of rationing dialysis treatment: The dilemma facing a developing country
Moosa, M. R., & Kidd, M. (2006) · Kidney International · doi:10.1038/sj.ki.5001750 · Cited by 155
Socioeconomic status and end-stage renal disease in the United States
Young, E. W., Mauger, E. A., Jiang, K.-H., Port, F. K., & Wolfe, R. A. (1994) · Kidney International · doi:10.1038/ki.1994.120 · Cited by 132
Dirks, J. H., de Zeeuw, D., Agarwal, S. K., Atkins, R. C., Correa‐Rotter, R., D’Amico, G., Bennett, P. H., Nahas, M. E., Valdés, R. H., Kaseje, D. A. N., et al. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09800.x · Cited by 122
A Report of the Lisbon Conference on the Care of the Kidney Transplant Recipient
Abbud‐Filho, M., Adams, P. L., Alberú, J., Cardella, C. J., Chapman, J. R., Cochat, P., Cosio, F., Danovitch, G. M., Davis, C. L., Gaston, R. S., et al. (2007) · Transplantation · doi:10.1097/01.tp.0000260765.41275.e2 · Cited by 112
Investing in Health for Economic Development
Lustig, N. C. (2006) · Cited by 104
Chronic kidney disease in Costa Rica
Cerdas, M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09705.x · Cited by 88
Waitzkin, H. B. (2015) · Routledge eBooks · doi:10.4324/9781315633473-13 · Cited by 55
Nephrology in South East Asia: Fact and concept
Sitprija, V. (2003) · Kidney International · doi:10.1046/j.1523-1755.63.s83.27.x · Cited by 48
Payment for living organ donation should be legalised
Friedman, A. L. (2006) · BMJ · doi:10.1136/bmj.38961.475718.68 · Cited by 47
Polypill holds promise for people with chronic disease.
Wise, J. (2005) · Europe PMC (PubMed Central) · Cited by 28
Correa‐Rotter, R., & Gonzalez-Michaca, L. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09813.x · Cited by 22
Cited by
Chronic kidney disease: global dimension and perspectives
Jha, V., Garcia-Garcia, G., Iseki, K., Li, Z., Naicker, S., Plattner, B., Saran, R., Wang, A. Y.-M., & Yang, C.-W. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60687-x · Cited by 4,383
Worldwide access to treatment for end-stage kidney disease: a systematic review
Liyanage, T., Ninomiya, T., Jha, V., Neal, B., Patrice, H. M., Okpechi, I., Zhao, M.-H., Lv, J., Garg, A. X., Knight, J., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61601-9 · Cited by 2,339
Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy
Thurlow, J. S., Joshi, M., Yan, G., Norris, K. C., Agodoa, L. Y., Yuan, C. M., & Nee, R. (2021) · American Journal of Nephrology · doi:10.1159/000514550 · Cited by 855
The current and future landscape of dialysis
Himmelfarb, J., Vanholder, R., Mehrotra, R., & Tonelli, M. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0315-4 · Cited by 650
Ene-Iordache, B., Perico, N., Bikbov, B., Carminati, S., Remuzzi, A., Perna, A., Islam, N., Bravo, R. F., Aleckovic-Halilovic, M., Zou, H., et al. (2016) · The Lancet Global Health · doi:10.1016/s2214-109x(16)00071-1 · Cited by 627
Metadata
- Authors
- White, S.
- Venue
- Bulletin of the World Health Organization
- Publisher
- WHO Press
- Published
- 2008-03-01
- Volume
- 86
- Issue
- 3
- Pages
- 229-237
- ISSN
- 0042-9686 (ISSN-L)
- OpenAlex
- W2107027176
- Cited by
- 291
- References
- 24
- FWCI
- 6.48
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.